Rosacea is associated with chronic systemic diseases in a skin severity–dependent manner: Results of a case-control study - 14/09/15
, Alexander H. Fischer, BS, Dimitre Luz Felipe da Silva, Sewon Kang, MD, Anna L. Chien, MDAbstract |
Background |
Rosacea is a common chronic inflammatory dermatosis of unclear origin. It has been associated with systemic comorbidities, but methodical studies addressing this association are lacking.
Objective |
We evaluated: (1) the association between rosacea and systemic comorbidities; and (2) if the severity of rosacea is impacted by comorbidities.
Methods |
This was a case-control study: patients with rosacea were matched (1:1) to rosacea-free control subjects by age, sex, and race. Relative risk estimates were calculated using logistic regression as odds ratios with 95% confidence intervals.
Results |
Among 130 participants (65 patients/65 control subjects), we observed a significant association between rosacea and allergies (airborne, food), respiratory diseases, gastroesophageal reflux disease, other gastrointestinal diseases, hypertension, metabolic and urogenital diseases, and female hormone imbalance. Compared with mild rosacea, moderate to severe rosacea was significantly associated with hyperlipidemia, hypertension, metabolic diseases, cardiovascular diseases, and gastroesophageal reflux disease.
Limitations |
This was a case-control study with moderate sample size. Associated medical conditions were self-reported and could not always be confirmed by medication use and medical records.
Conclusions |
Rosacea is associated with numerous systemic comorbid diseases in a skin severity–dependent manner. Physicians should be aware of these associations to provide comprehensive care to patients with rosacea, especially to those with more severe disease.
Le texte complet de cet article est disponible en PDF.Key words : case-control study, comorbidity, rosacea, severity, systemic disease
Abbreviations used : CI, CVD, GERD, GI, OR
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 73 - N° 4
P. 604-608 - octobre 2015 Retour au numéro
Article précédent
- Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
- Ian Landells, Colleen Marano, Ming-Chun Hsu, Shu Li, Yaowei Zhu, Lawrence F. Eichenfield, Peter H. Hoeger, Alan Menter, Amy S. Paller, Alain Taieb, Sandra Philipp, Philippe Szapary, Bruce Randazzo
- Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa
- Amrit Khalsa, Guodong Liu, Joslyn S. Kirby
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?